Cite

HARVARD Citation

    Andersson, N. et al. (2018). Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation. International journal of cardiology. pp. 113-119. [Online]. 
  
Back to record